Currently Browsing

Our Products

Fenofibric Acid Delayed-Release Capsules 45 mg – 90/Bottle

Overview

Reference Brand:
Trilipix®
Therapeutic Class:
Cardiovascular

Specifications

GCN:
16104
Strength:
45 mg
Size:
90
NDC #:
59651021690
TE Code:
AB

Order Information

Case Qty (min order qty):
48
Case Weight (lbs):
4.852

Attributes

Physical Form:
Capsules
Shape:
Capsules
Color:
Orange/Yellow
Imprint:
"CFB" / "45"
Prescribing Info
Product News

February 18, 2026 | Aurobindo Receives FDA Approval for Aripiprazole Orally Disintegrating Tablets USP, 10 mg and 15 mg ... Read more

Product News

January 26, 2026 | Aurobindo Receives FDA Approval for Betamethasone Dipropionate Cream USP, 0.05% ... Read more

Product News

January 21, 2026 | Aurobindo Receives FDA Approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg ... Read more